S-1 and raltitrexed for patients with metastatic colorectal cancer after failure to fluoropyrimidine, irinotecan and oxaliplatin.
收藏NIAID Data Ecosystem2026-03-08 收录
官方服务：
资源简介：
Interventions: experimental group:S-1 and raltitrexed Primary outcome(s): progression - free survival;tumor objective response rate Study Design: Case series
创建时间：
2015-07-15
